US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist
  • 11.000
  • +0.220+2.04%
Trading Apr 16 15:31 ET
1.10BMarket Cap-7006P/E (TTM)

Centessa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
6.85M
6.85M
0
0
0
0
0
0
0
0
Operating revenue
--6.85M
--6.85M
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-15.29%178.14M
1.03%42.03M
-17.99%40.21M
-31.27%47.02M
-4.61%48.88M
210.28M
41.6M
27.96%49.03M
128.24%68.41M
51.24M
Selling and administrative expenses
-2.66%53.73M
-10.55%12.32M
-2.16%12.02M
-9.60%13.35M
11.58%16.05M
--55.2M
--13.77M
-1.44%12.28M
24.68%14.76M
--14.39M
-General and administrative expense
-2.66%53.73M
-10.55%12.32M
-2.16%12.02M
-9.60%13.35M
11.58%16.05M
--55.2M
--13.77M
-1.44%12.28M
24.68%14.76M
--14.39M
Research and development costs
-19.78%124.41M
6.76%29.72M
-23.28%28.19M
-37.24%33.67M
-10.93%32.83M
--155.08M
--27.84M
42.14%36.74M
195.86%53.65M
--36.85M
Operating profit
18.55%-171.28M
15.44%-35.18M
17.99%-40.21M
31.27%-47.02M
4.61%-48.88M
-210.28M
-41.6M
-27.96%-49.03M
-128.24%-68.41M
-51.24M
Net non-operating interest income expense
108.10%570K
116.77%363K
122.33%412K
75.98%-391K
113.32%186K
-7.03M
-2.16M
-2,938.46%-1.85M
-6,129.63%-1.63M
-1.4M
Non-operating interest income
4,193.44%10.48M
7,420.51%2.93M
3,735.06%2.95M
8,136.00%2.06M
2,333.65%2.53M
--244K
--39K
18.46%77K
-7.41%25K
--104K
Non-operating interest expense
36.13%9.91M
16.66%2.57M
32.21%2.54M
48.22%2.45M
56.33%2.35M
--7.28M
--2.2M
--1.92M
--1.65M
--1.5M
Other net income (expense)
-1,599.45%-5.43M
-1,154.29%-878K
46.64%-1.68M
-128.49%-1.53M
24.55%-1.35M
362K
-70K
-64.90%-3.14M
146.59%5.36M
-1.78M
Special income (charges)
--0
--0
--0
--0
--0
---1.98M
--0
--0
--0
---1.98M
-Less：Restructuring and merger&acquisition
--0
--0
--0
--0
--0
--1.98M
--0
--0
--0
--1.98M
Other non- operating income (expenses)
-331.77%-5.43M
-1,154.29%-878K
46.64%-1.68M
-128.49%-1.53M
-786.73%-1.35M
--2.34M
---70K
-64.90%-3.14M
2,905.76%5.36M
--196K
Income before tax
18.81%-176.14M
18.58%-35.69M
23.22%-41.47M
24.34%-48.94M
8.05%-50.04M
-216.95M
-43.84M
-34.52%-54.02M
-56.05%-64.68M
-54.42M
Income tax
-3,254.22%-25.06M
272.29%1.14M
-1,904.26%-2.83M
-109,222.73%-24.05M
746.25%677K
-747K
-664K
-141K
-22K
80K
Net income
30.12%-151.09M
14.68%-36.84M
28.26%-38.65M
61.51%-24.89M
6.94%-50.71M
-216.21M
-43.17M
-34.17%-53.88M
-55.99%-64.66M
-54.5M
Net income continuous Operations
30.12%-151.09M
14.68%-36.84M
28.26%-38.65M
61.51%-24.89M
6.94%-50.71M
---216.21M
---43.17M
-34.17%-53.88M
-55.99%-64.66M
---54.5M
Minority interest income
Net income attributable to the parent company
30.12%-151.09M
14.68%-36.84M
28.26%-38.65M
61.51%-24.89M
6.94%-50.71M
-216.21M
-43.17M
-34.17%-53.88M
-55.99%-64.66M
-54.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.12%-151.09M
14.68%-36.84M
28.26%-38.65M
61.51%-24.89M
6.94%-50.71M
-216.21M
-43.17M
-34.17%-53.88M
-55.99%-64.66M
-54.5M
Basic earnings per share
32.03%-1.57
17.78%-0.37
29.82%-0.4
62.32%-0.26
11.67%-0.53
-2.31
33.82%-0.45
-26.67%-0.57
-6.15%-0.69
-0.6
Diluted earnings per share
32.03%-1.57
17.78%-0.37
29.82%-0.4
62.32%-0.26
11.67%-0.53
-2.31
33.82%-0.45
-26.67%-0.57
-6.15%-0.69
-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 6.85M6.85M00000000
Operating revenue --6.85M--6.85M--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -15.29%178.14M1.03%42.03M-17.99%40.21M-31.27%47.02M-4.61%48.88M210.28M41.6M27.96%49.03M128.24%68.41M51.24M
Selling and administrative expenses -2.66%53.73M-10.55%12.32M-2.16%12.02M-9.60%13.35M11.58%16.05M--55.2M--13.77M-1.44%12.28M24.68%14.76M--14.39M
-General and administrative expense -2.66%53.73M-10.55%12.32M-2.16%12.02M-9.60%13.35M11.58%16.05M--55.2M--13.77M-1.44%12.28M24.68%14.76M--14.39M
Research and development costs -19.78%124.41M6.76%29.72M-23.28%28.19M-37.24%33.67M-10.93%32.83M--155.08M--27.84M42.14%36.74M195.86%53.65M--36.85M
Operating profit 18.55%-171.28M15.44%-35.18M17.99%-40.21M31.27%-47.02M4.61%-48.88M-210.28M-41.6M-27.96%-49.03M-128.24%-68.41M-51.24M
Net non-operating interest income expense 108.10%570K116.77%363K122.33%412K75.98%-391K113.32%186K-7.03M-2.16M-2,938.46%-1.85M-6,129.63%-1.63M-1.4M
Non-operating interest income 4,193.44%10.48M7,420.51%2.93M3,735.06%2.95M8,136.00%2.06M2,333.65%2.53M--244K--39K18.46%77K-7.41%25K--104K
Non-operating interest expense 36.13%9.91M16.66%2.57M32.21%2.54M48.22%2.45M56.33%2.35M--7.28M--2.2M--1.92M--1.65M--1.5M
Other net income (expense) -1,599.45%-5.43M-1,154.29%-878K46.64%-1.68M-128.49%-1.53M24.55%-1.35M362K-70K-64.90%-3.14M146.59%5.36M-1.78M
Special income (charges) --0--0--0--0--0---1.98M--0--0--0---1.98M
-Less：Restructuring and merger&acquisition --0--0--0--0--0--1.98M--0--0--0--1.98M
Other non- operating income (expenses) -331.77%-5.43M-1,154.29%-878K46.64%-1.68M-128.49%-1.53M-786.73%-1.35M--2.34M---70K-64.90%-3.14M2,905.76%5.36M--196K
Income before tax 18.81%-176.14M18.58%-35.69M23.22%-41.47M24.34%-48.94M8.05%-50.04M-216.95M-43.84M-34.52%-54.02M-56.05%-64.68M-54.42M
Income tax -3,254.22%-25.06M272.29%1.14M-1,904.26%-2.83M-109,222.73%-24.05M746.25%677K-747K-664K-141K-22K80K
Net income 30.12%-151.09M14.68%-36.84M28.26%-38.65M61.51%-24.89M6.94%-50.71M-216.21M-43.17M-34.17%-53.88M-55.99%-64.66M-54.5M
Net income continuous Operations 30.12%-151.09M14.68%-36.84M28.26%-38.65M61.51%-24.89M6.94%-50.71M---216.21M---43.17M-34.17%-53.88M-55.99%-64.66M---54.5M
Minority interest income
Net income attributable to the parent company 30.12%-151.09M14.68%-36.84M28.26%-38.65M61.51%-24.89M6.94%-50.71M-216.21M-43.17M-34.17%-53.88M-55.99%-64.66M-54.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.12%-151.09M14.68%-36.84M28.26%-38.65M61.51%-24.89M6.94%-50.71M-216.21M-43.17M-34.17%-53.88M-55.99%-64.66M-54.5M
Basic earnings per share 32.03%-1.5717.78%-0.3729.82%-0.462.32%-0.2611.67%-0.53-2.3133.82%-0.45-26.67%-0.57-6.15%-0.69-0.6
Diluted earnings per share 32.03%-1.5717.78%-0.3729.82%-0.462.32%-0.2611.67%-0.53-2.3133.82%-0.45-26.67%-0.57-6.15%-0.69-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg